Dear Shareholder,

Ref : Strides Pharma Science Limited (‘Strides’/ ‘the Company’)

Subject: : Deduction of Tax at Source (TDS) on Dividend pay-out for FY2025

We hope that you and your family are doing well and are safe and healthy.

We wish to inform you that Board of Directors of the Company in their meeting held on May 22, 2025 recommended a Final Dividend of Rs. 4 per equity share having nominal value of Rs. 10/- each for the Financial Year (‘FY’) ended March 31, 2025, subject to shareholders’ approval at the ensuing Annual General Meeting (‘AGM’) to be held on Thursday, August 07, 2025.

As you are aware, as per the Income-Tax Act, 1961, (‘the Act’), as amended by the Finance Act, 2020, dividend paid or distributed by a company on or after April 1, 2020 shall be taxable in the hands of the shareholders. Therefore, the Company shall be required to deduct taxes at source at the rates applicable to each category of shareholder as per the relevant provisions of the Act. The TDS for various categories of shareholders along with required documents are provided below.

As per the latest information available with the depositories (NSDL/ CDSL)/ Registrar and Share Transfer Agent (‘KFin Technologies Limited’ or ‘KFintech’), you are a shareholder of the Company. If you remain as a shareholder as on the Record Date i.e., Tuesday, July 22, 2025, dividend receivable by you would be taxable under the Act. Hence, we request you to kindly verify the correctness of your records (including Residential status as per the Act for FY 2025-26, Permanent Account Number (‘PAN’), Aadhaar number (in case of individual shareholders), bank account details, Email ID, Address and Contact phone number) and update the same with your depository participant (if you hold shares in dematerialized mode) or the Registrar and Share Transfer Agent (if you hold shares in physical mode), at the earliest. Please note that for the purpose of complying with the applicable provisions on Tax Deducted at Source (TDS), the Company will rely on the above-mentioned details in the Register of Members as on Tuesday, July 22, 2025.

Shareholders holding shares in physical folios are requested to note that SEBI vide its Circular No. SEBI/ HO/ MIRSD/ MIRSD_RTAMB/ P/ CIR/ 2021/ 655 dated November 3, 2021 (subsequently amended by Circular Nos. SEBI/ HO/ MIRSD/ MIRSD_RTAMB/ P/ CIR/ 2021/ 687 dated December 14, 2021, SEBI/ HO/ MIRSD/ MIRSD-PoD-1/ P/ CIR/ 2023/ 37 March 16, 2023 and SEBI/ HO/ MIRSD/ POD-1/ P/ CIR/ 2023/ 181 November 17, 2023) has mandated that with effect from April 1, 2024, dividend to security holders (holding securities in physical form), shall be paid only through electronic mode. Such payment shall be made only after furnishing the PAN, choice of nomination, contact details including mobile number, bank account details and specimen signature.

In case your shareholding is in the physical form, you will have to submit a scanned copy of a covering letter, duly signed by the first shareholder, along with a cancelled cheque leaf with your name and bank account details and a copy of your PAN card, duly self-attested, with Company’s RTA. This will facilitate receipt of dividend directly into your bank account. In case the cancelled cheque leaf does not bear your name, please attach a copy of the bank pass-book statement, duly self-attested.

We also request the shareholders holding shares in dematerialized mode to register their email address and mobile number with their relevant depositories through their depositary participants.

Shareholders holding shares in physical mode are hereby notified that based on SEBI Circular number SEBI/ HO/ MIRSD/ MIRSD-PoD-1/ P/ CIR/ 2023/ 37, dated March 16, 2023, all holders of physical securities in listed companies shall register the postal address with PIN for their corresponding folio numbers.

It shall be mandatory for the security holders to provide mobile number. Physical Holders can register/ update the contact details through submitting the requisite ISR 1 form along with the supporting documents.

ISR 1 Form can be obtained by following the link:

https://ris.kfintech.com/clientservices/isc/isrforms.aspx https://www.strides.com/Shareholders_service_request.html
ISR Form(s) and the supporting documents can be provided by any one of the following modes:

a) Through ‘In Person Verification’ (IPV): the authorized person of the RTA shall verify the original documents furnished by the investor and retain copy(ies) with IPV stamping with date and initials

b) Through hard copies which are self-attested, which can be shared on the address below

Name	KFIN Technologies Limited         Unit: Strides Pharma Science Limited
Address	Selenium Building, Tower-B,           Plot No 31 & 32, Financial District,     Nanakramguda, Serilingampally,     Hyderabad, Rangareddy,     Telangana India - 500 032.

c) Through electronic mode with e-sign by following the link:

https://ris.kfintech.com/clientservices/isc/default.aspx#

Detailed FAQ can be found on the link: https://ris.kfintech.com/faq.html

RELEVANT TAX PROVISIONS FOR TDS AND DOCUMENTS REQUIRED FROM RESPECTIVE CATEGORY OF SHAREHOLDERS

---

I. For Resident Shareholders

Tax is required to be deducted on dividend income under section 194 of the Act at 10% where shareholders have registered their valid PAN. However, please note that if you do not furnish PAN or PAN is not valid, it would be considered as PAN not being available and taxes would be deducted at 20% as per section 206AA of the Act

• Resident Individual Shareholders

  No tax shall be deducted on the dividend payable to resident individuals, if:

  1. 1. Total dividend to be received by you from Strides during the FY 2025-2025 does not exceed Rs. 10,000/-.

  2. In order to provide exemption from TDS on the dividend payable to you, you should submit all the following documents, if eligible, as per the relevant provisions of the Act:

     1. a. Form No. 15G (applicable to Resident Individuals); Form No. 15H (applicable in case of Resident Individual’s age is 60 years or more) provided that all eligibility conditions are met – The link to download the forms is provided below.

        Please note that PAN is mandatory while providing Form No. 15G/ Form No. 15H, failing which tax would be deducted @20% as per Section 206AA of the Act.

     2. b. Lower deduction tax / Nil tax certificate for the FY 2025-2025, if any, obtained from the Income Tax authorities;

  If the above documents are found in accordance with the provisions of the Act, the same shall be considered while deducting the taxes.

• Resident Non – Individual Shareholders

  In case your income is subject to lower rate of TDS, or is exempt under the Act, you should submit the following, as applicable:

  1. For Mutual Funds/ Insurance companies/ AIF (with Category I/ II status): A self-declaration in the format as provided in the link below (as relevant) along with the documentary evidence.
  2. For Others (Resident Company / Firm / HUF / AOP / Trust / Local Authority / Artificial Juridical Person, etc): In case you are a specified person covered under section 196 of the Act or you have tax exemption status under section 197A of the Act read with Circular No. 18/2017, submit a self-declaration as provided in the link below (as relevant) along with the documentary evidence.
  3. Lower deduction tax certificate for the FY 2025-2026, if any obtained from the Income Tax authorities

  If the above documents are found in accordance with the provisions of the Act, the same shall be considered while deducting the taxes.

---

II. For Non-resident Shareholders

• Non- resident shareholder including Foreign Institutional Investors (FIIs) / Foreign Portfolio Investors FPIs

Taxes are required to be deducted in accordance with the provisions of section 195, section 196D and other applicable provisions of the Act as per the rates in force i.e. the TDS rate shall be at 20% (plus applicable surcharge and cess) on the amount of dividend. However, as per Section 90 of the Act, you have an option to be governed by the provisions of the Double Taxation Avoidance Agreement ('DTAA') between India and the country of your tax residence, if they are more beneficial to you, read with the provisions laid down in Multilateral Instrument (‘MLI’). In case you propose to avail the benefit of DTAA, read with the MLI between India and the country of your tax residence, you should submit all the following documents as prescribed under the Act:

1. Self-attested copy of the Permanent Account Number (‘PAN Card’) allotted by the Indian income tax authorities. In case, PAN is not available, the non-resident shareholder shall furnish (a) name, (b) email id, (c) contact number, (d) address in residency country, (e) self-attested copy of the Tax Residency Certificate from the resident country and (f) Tax Identification Number of the residency country, as prescribed under Rule 37BC of the Income-tax Rules, 1962 (‘the Rules’).
2. Self-attested copy of Tax Residency Certificate (‘TRC’) for the FY 2023-2024 (for the period April 2023 to March 2024) obtained from the revenue authorities of the country of your residence;
3. Shareholders holding PAN to submit Form No. 10F (valid for the period April 01, 2025 to March 31, 2026) electronically filed on the Indian Income Tax web portal. Further, in case of shareholder not having a valid PAN and not required to obtain a PAN in India, online Form 10F can be generated via registering as “Others” on the income tax e-filing portal https://eportal.incometax.gov.in/iec/foservices/#/pre-login/register and category as “Non- Resident not having PAN and not required to obtain PAN”.
4. Self-declaration in the format as provided in the link below that you are eligible to avail the DTAA benefits;
5. Copy of SEBI registration certificate in case of Foreign Institutional Investors and Foreign Portfolio Investors;
6. Any other document as prescribed under the Act for lower rate of tax, if applicable and as obtained from the India Income Tax authorities

If the above documents are found in accordance with the provisions of the Income-tax Act, 1961, the same shall be considered while deducting the taxes. Further, please note that the Company is not obligated to apply the beneficial DTAA rates at the time of tax deduction on the dividend amount. The application of beneficial DTAA rate shall depend upon the completeness and satisfactory review by the Company, of the documents submitted by the Non-resident shareholders.

• Submitting Order under Section 195/197 of the Act

Shareholders are required to provide self- attested copy of Lower/NIL withholding tax certificate obtained from Income Tax Authorities

---

III. For Shareholders Having Multiple Accounts Under Different Status / Category:

Shareholders holding equity shares in the Company under multiple accounts under different status/ category and single PAN, may note that higher of the tax as applicable to the status in which shares are held under a PAN will be considered on their entire holding in different accounts.

Declaration under Rule 37BA of the Rules

In terms of Rule 37BA of the Rules, if dividend income on which tax has been deducted at source is assessable in the hands of a person other than the deductee, then deductee should submit a self-certified declaration with the Company in the manner prescribed by the said Rule, which shall contain the name, address, PAN of the person to whom credit is to be given, payment or credit in relation to which credit is to be given and reasons for giving credit to such person. Accordingly, in case where shares are held by intermediaries / stock brokers and TDS is to be applied by the Company on the PAN of the beneficial Shareholders, then such intermediaries / stock brokers and beneficial shareholders will have to provide a declaration in the prescribed format under Rule 37BA of the Act. Hence, such registered Shareholder (i.e. the said clearing member, stock broker etc.) are required to furnish to the Company latest by July 22, 2025, a declaration containing the name, address, residential status and PAN of the actual beneficial owner to whom TDS credit is to be given, and reasons for giving credit to such person. The format of declaration under Rule 37BA of the Act is provided below.

No request in this regard will be considered by the Company after July 22, 2025.

You may note that the Company has notified Record Date for the Final Dividend for FY 2024-2025 as Tuesday,July 22, 2025 to the Stock Exchanges. We request you to kindly take note accordingly.

Kindly note that the aforementioned documents, where ever applicable for respective category of shareholders above should be uploaded with KFin Technologies Limited, the Registrar and Transfer Agent ("KFintech") at https://ris.kfintech.com/form15. The above documents should reach us latest by 17:00 hrs IST on or before Friday, August 04, 2023, in order to enable the Company to determine and deduct appropriate TDS / withholding tax rate.

No communication/ documents on the tax determination/ deduction shall be entertained after July 22, 2025. We request you to kindly take note accordingly. The Company is obligated to deduct TDS based on the records available with RTA and no request will be entertained for revision of TDS return.

It may be further noted that in case the tax on the said dividend is deducted in the absence of receipt of the aforementioned details/ documents from you, there would still be an option available with you to file the return of income and claim an appropriate refund, if eligible. Incomplete and / or unsigned forms, declarations and documents will not be considered by the Company for granting any exemption. No claim shall lie against the Company for taxes once deducted.

In the event of any income tax demand (including interest, penalty, etc.) arising from any misrepresentation, inaccuracy or omission of information provided / to be provided by the Shareholder(s), such Shareholder(s) will be responsible to indemnify the Company and also, provide the Company with all information / documents and co-operation in any appellate proceedings.

The Company shall make arrangements for sending the TDS certificate, when taxes deducted, to the shareholders at their registered email-id in due course, once the dividend payment has been made. Shareholders can also view the TDS credit in Form 26AS, which can be downloaded from the e-filing website of the income-tax department - https://incometaxindiaefiling.gov.in

Above communication on TDS sets out the provisions of Income-tax Act, 1961 as applicable in a summary manner only and does not purport to be a complete analysis or listing of all potential tax consequences. Shareholders should consult with their own tax advisors for the tax provisions that may be applicable to them.

Disclaimer:

This communication shall not be treated as a tax advice from the Company or its Registrar & Transfer Agent. Shareholders should obtain the tax advice related to their tax matters from a tax professional.

We seek your co-operation in the matter.

Please reach out to us at investors@strides.comor einward.ris@kfintech.com (Toll Free No. 1-800-309-4001) for any queries.

Thanks and Regards,
For Strides Pharma Science Limited,
sd/-
Manjula Ramamurthy
Company Secretary